Infant leukaemia - faithful models, cell of origin and the niche

Area of Science:

• Paediatric Oncology
• Developmental Biology
• Cancer Research

Background:

• Infant leukaemia presents unique challenges, with poorer outcomes than other paediatric leukaemias.
• Distinct biological features include MLL-gene rearrangements, aggressive behaviour, lineage plasticity, and frequent central nervous system involvement.
• Understanding the embryonic origins and microenvironment is crucial for infant leukaemia development.

Purpose of the Study:

• To review current in vitro, ex vivo, and in vivo models of infant leukaemia.
• To explore how these models advance understanding of the leukaemia niche in embryonic development and established disease.
• To highlight the role of modelling in identifying novel therapeutic strategies.

Main Methods:

• Review of existing literature on infant leukaemia models.
• Analysis of how different model systems (in vitro, ex vivo, in vivo) illuminate leukaemic niche interactions.
• Discussion of insights gained from studying embryonic haematopoiesis and specialised non-haematopoietic niches.

Main Results:

• Infant leukaemia models provide critical insights into the disease's distinct biological characteristics.
• These models help elucidate the interactions between leukaemic cells and their microenvironment (niche).
• Understanding the embryonic context and niche is essential for deciphering infant leukaemia pathogenesis.

Conclusions:

• Accurate modelling systems are essential for investigating rare infant leukaemias with prenatal origins.
• Mechanistic insights from these models are vital for developing effective novel therapeutic options.
• Further research using advanced models will improve outcomes for infant leukaemia patients.